Meeting of the Board of Scientific Counselors, National Institute for Occupational Safety and Health, 7714-7715 [2024-02180]
Download as PDF
<![CDATA[
7714
Federal Register / Vol. 89, No. 24 / Monday, February 5, 2024 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Application for Permit to Import Biological Agents, Infectious Substances and
Vectors of Human Disease into the
United States.
Application for Permit to Import Biological Agents, Infectious Substances and
Vectors of Human Disease into the
United States Subsequent Transfer.
Application for a Permit to Import Live
Bats.
Application for Permit to Import Infectious Human Remains into the United
States.
Importer Certification Statement .............
2,000
1
30/60
1,000
380
1
10/60
63
3
1
20/60
1
100
1
20/60
33
2,000
1
30/60
1,000
..................................................................
....................
........................
....................
2,097
Form name
Applicants Requesting to Import Biological Agents, Infectious Substances and
Vectors.
Applicants Requesting to Import Biological Agents, Infectious Substances and
Vectors.
Applicants Requesting to Import Live
Bats.
Applicants Requesting to Import Infectious Human Remains into the United
States.
Importers of Non-infectious Materials to
the United States.
Total ..................................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2024–02173 Filed 2–2–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Lead Exposure and Prevention
Advisory Committee (LEPAC); Notice
of Charter Renewal
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of charter renewal.
AGENCY:
This gives notice under the
Federal Advisory Committee Act of
October 6, 1972, that the Lead Exposure
and Prevention Advisory Committee
(LEPAC), Centers for Disease Control
and Prevention, Department of Health
and Human Services, has been renewed
for a 2-year period through January 17,
2026.
FOR FURTHER INFORMATION CONTACT: Paul
Allwood, Ph.D., MPH, Designated
Federal Officer, National Center for
Environmental Health, Centers for
Disease Control and Prevention,
Department of Health and Human
Services, 1600 Clifton Road NE, MS
S106–5, Atlanta, Georgia 30329–4018.
Telephone (770) 488–6774; PAllwood@
cdc.gov.
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
CDC is
providing notice under 5 U.S.C. 1001–
SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014
17:56 Feb 02, 2024
Jkt 262001
Average
burden per
response
(in hours)
Number of
respondents
Type of respondents
1014 of the renewal of the charter of the
Lead Exposure and Prevention Advisory
Committee, Centers for Disease Control
and Prevention, Department of Health
and Human Services. This charter has
been renewed for a two-year period
through January 17, 2026.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–02179 Filed 2–2–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2024–0009; NIOSH–278]
Meeting of the Board of Scientific
Counselors, National Institute for
Occupational Safety and Health
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting and request
for comment.
AGENCY:
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
Total
burden
(in hours)
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC) announces the
following meeting of the Board of
Scientific Counselors, National Institute
for Occupational Safety and Health
(BSC, NIOSH). This is a virtual meeting.
It is open to the public, limited only by
the number of web conference lines (500
lines are available). Time will be
available for public comment.
DATES: The meeting will be held on
March 13, 2024, from 10 a.m. to 3:30
p.m., EDT.
Written comments must be received
on or before March 6, 2024.
ADDRESSES: If you wish to attend the
meeting, please register at the NIOSH
website at https://www.cdc.gov/niosh/
bsc/ or by telephone at (202) 245–0649
no later than March 6, 2024.
You may submit comments, identified
by Docket No. CDC–2024–0009;
NIOSH–278, by either of the methods
listed below. CDC does not accept
comments by email.
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Ms. Sherri Diana, NIOSH
Docket Office, National Institute for
Occupational Safety and Health, 1090
Tusculum Avenue, Mailstop C–34,
Cincinnati, Ohio 45226. Attn: Docket
No. CDC–2024–0009; NIOSH–278.
Instructions: All submissions received
must include the Agency name and
docket number. Docket number CDC–
2024–0009; NIOSH–278 will close
March 6, 2024.
FOR FURTHER INFORMATION CONTACT:
Maria Strickland, M.P.H., Designated
Federal Officer, Board of Scientific
SUMMARY:
E:\FR\FM\05FEN1.SGM
05FEN1
Federal Register / Vol. 89, No. 24 / Monday, February 5, 2024 / Notices
lotter on DSK11XQN23PROD with NOTICES1
Counselors, National Institute for
Occupational Safety and Health, Centers
for Disease Control and Prevention,
Constitution Center, 400 7th Street SW,
Suite 5W, Washington, District of
Columbia 20024. Telephone: (202) 245–
0649; Email: MStrickland2@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: The Secretary of Health
and Human Services, the Assistant
Secretary for Health, and by delegation
the Director, Centers for Disease Control
and Prevention, are authorized under
Sections 301 and 308 of the Public
Health Service Act to conduct directly,
or by grants or contracts, research,
experiments, and demonstrations
relating to occupational safety and
health and to mine health.
Purpose: The Board of Scientific
Counselors, National Institute for
Occupational Safety and Health (BSC,
NIOSH) provides advice to the Director,
National Institute for Occupational
Safety and Health, on NIOSH research
and prevention programs. The Board
also provides guidance on the Institute’s
research activities related to developing
and evaluating hypotheses,
systematically documenting findings,
and disseminating results. In addition,
the Board evaluates the degree to which
the activities of NIOSH: (1) conform to
those standards of scientific excellence
appropriate for Federal scientific
institutions in accomplishing objectives
in occupational safety and health; (2)
address currently relevant needs in the
fields of occupational safety and health
either alone or in conjunction with
other known activities inside and
outside of NIOSH; and (3) produce their
intended results in addressing
important research questions in
occupational safety and health, both in
terms of applicability of the research
findings and dissemination of the
findings.
Matters To Be Considered: The agenda
for the meeting addresses the NIOSH
Evaluation Capacity Building Plan (ECB
Plan) and Scoring Progress on the ECB
Plan; Diversity, Equity, and Inclusion at
NIOSH; and a National Firefighter
Registry Subcommittee Update. Agenda
items are subject to change as priorities
dictate.
The agenda is also posted on the
NIOSH website at https://www.cdc.gov/
niosh/bsc/.
Public Participation
Written Public Comment: Written
comments will be accepted per the
instructions provided in the addresses
section above. Comments received in
advance of the meeting are part of the
public record and are subject to public
disclosure. Written comments will be
VerDate Sep<11>2014
17:56 Feb 02, 2024
Jkt 262001
included in the official record of the
meeting. Do not include any
information in your comment or
supporting materials that you consider
confidential or inappropriate for public
disclosure. If you include your name,
contact information, or other
information that identifies you in the
body of your comments, that
information will be on public display.
CDC will review all submissions and
may choose to redact, or withhold,
submissions containing private or
proprietary information such as Social
Security numbers, medical information,
inappropriate language, or duplicate/
near-duplicate examples of a mass-mail
campaign. CDC will carefully consider
all comments submitted into the docket.
Written comments received by March
6, 2024, will be provided to the Board
prior to the meeting.
Oral Public Comment: The public is
welcome to participate during the
public comment period, from 1 p.m. to
1:15 p.m., EDT, March 13, 2024. Each
commenter will be provided up to five
minutes for comment. A limited number
of time slots are available and will be
assigned on a first-come, first-served
basis. Members of the public who wish
to address the BSC, NIOSH are
requested to contact the Designated
Federal Officer for scheduling purposes
(see FOR FURTHER INFORMATION CONTACT
above).
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–02180 Filed 2–2–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–24–0728]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
7715
has submitted the information
collection request titled ‘‘National
Notifiable Diseases Surveillance System
(NNDSS)’’ to the Office of Management
and Budget (OMB) for review and
approval. CDC previously published a
‘‘Proposed Data Collection Submitted
for Public Comment and
Recommendations’’ notice on November
14, 2023 to obtain comments from the
public and affected agencies. CDC
received one comment related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
E:\FR\FM\05FEN1.SGM
05FEN1
]]>Agencies
[Federal Register Volume 89, Number 24 (Monday, February 5, 2024)]
[Notices]
[Pages 7714-7715]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-02180]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2024-0009; NIOSH-278]
Meeting of the Board of Scientific Counselors, National Institute
for Occupational Safety and Health
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting and request for comment.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC) announces the
following meeting of the Board of Scientific Counselors, National
Institute for Occupational Safety and Health (BSC, NIOSH). This is a
virtual meeting. It is open to the public, limited only by the number
of web conference lines (500 lines are available). Time will be
available for public comment.
DATES: The meeting will be held on March 13, 2024, from 10 a.m. to 3:30
p.m., EDT.
Written comments must be received on or before March 6, 2024.
ADDRESSES: If you wish to attend the meeting, please register at the
NIOSH website at https://www.cdc.gov/niosh/bsc/ or by telephone at
(202) 245-0649 no later than March 6, 2024.
You may submit comments, identified by Docket No. CDC-2024-0009;
NIOSH-278, by either of the methods listed below. CDC does not accept
comments by email.
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments.
Mail: Ms. Sherri Diana, NIOSH Docket Office, National
Institute for Occupational Safety and Health, 1090 Tusculum Avenue,
Mailstop C-34, Cincinnati, Ohio 45226. Attn: Docket No. CDC-2024-0009;
NIOSH-278.
Instructions: All submissions received must include the Agency name
and docket number. Docket number CDC-2024-0009; NIOSH-278 will close
March 6, 2024.
FOR FURTHER INFORMATION CONTACT: Maria Strickland, M.P.H., Designated
Federal Officer, Board of Scientific
[[Page 7715]]
Counselors, National Institute for Occupational Safety and Health,
Centers for Disease Control and Prevention, Constitution Center, 400
7th Street SW, Suite 5W, Washington, District of Columbia 20024.
Telephone: (202) 245-0649; Email: [email protected].
SUPPLEMENTARY INFORMATION:
Background: The Secretary of Health and Human Services, the
Assistant Secretary for Health, and by delegation the Director, Centers
for Disease Control and Prevention, are authorized under Sections 301
and 308 of the Public Health Service Act to conduct directly, or by
grants or contracts, research, experiments, and demonstrations relating
to occupational safety and health and to mine health.
Purpose: The Board of Scientific Counselors, National Institute for
Occupational Safety and Health (BSC, NIOSH) provides advice to the
Director, National Institute for Occupational Safety and Health, on
NIOSH research and prevention programs. The Board also provides
guidance on the Institute's research activities related to developing
and evaluating hypotheses, systematically documenting findings, and
disseminating results. In addition, the Board evaluates the degree to
which the activities of NIOSH: (1) conform to those standards of
scientific excellence appropriate for Federal scientific institutions
in accomplishing objectives in occupational safety and health; (2)
address currently relevant needs in the fields of occupational safety
and health either alone or in conjunction with other known activities
inside and outside of NIOSH; and (3) produce their intended results in
addressing important research questions in occupational safety and
health, both in terms of applicability of the research findings and
dissemination of the findings.
Matters To Be Considered: The agenda for the meeting addresses the
NIOSH Evaluation Capacity Building Plan (ECB Plan) and Scoring Progress
on the ECB Plan; Diversity, Equity, and Inclusion at NIOSH; and a
National Firefighter Registry Subcommittee Update. Agenda items are
subject to change as priorities dictate.
The agenda is also posted on the NIOSH website at https://www.cdc.gov/niosh/bsc/.
Public Participation
Written Public Comment: Written comments will be accepted per the
instructions provided in the addresses section above. Comments received
in advance of the meeting are part of the public record and are subject
to public disclosure. Written comments will be included in the official
record of the meeting. Do not include any information in your comment
or supporting materials that you consider confidential or inappropriate
for public disclosure. If you include your name, contact information,
or other information that identifies you in the body of your comments,
that information will be on public display. CDC will review all
submissions and may choose to redact, or withhold, submissions
containing private or proprietary information such as Social Security
numbers, medical information, inappropriate language, or duplicate/
near-duplicate examples of a mass-mail campaign. CDC will carefully
consider all comments submitted into the docket.
Written comments received by March 6, 2024, will be provided to the
Board prior to the meeting.
Oral Public Comment: The public is welcome to participate during
the public comment period, from 1 p.m. to 1:15 p.m., EDT, March 13,
2024. Each commenter will be provided up to five minutes for comment. A
limited number of time slots are available and will be assigned on a
first-come, first-served basis. Members of the public who wish to
address the BSC, NIOSH are requested to contact the Designated Federal
Officer for scheduling purposes (see FOR FURTHER INFORMATION CONTACT
above).
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-02180 Filed 2-2-24; 8:45 am]
BILLING CODE 4163-18-P
